top of page

Eyes on Pharma
Check-out What Intel Caught our Eye

Robin Bateman
1 day ago2 min read
2025 FDA Approvals - January Approvals
Here at PharmaTell, we have Eyes on FDA Approvals for 2025. Below, we share the monthly Novel Drug and Biologic License Application Approval

Jana Chisholm
Dec 11, 202416 min read
Eyes on 3Q24 Financial Results
We've highlighted a few firms: Lilly, AbbVie, Pfizer, Novo Nordisk, BMS, Roche, Novartis, Merck, AstraZeneca, GSK, Viatris, Teva, and Amgen.

Jana Chisholm
Sep 6, 20245 min read
August News Highlights
We've had our Eyes On some of the latest Pharmaceutical news including approvals, partnering, mergers, research programs, and


Jana Chisholm
Jun 5, 20244 min read
Eyes on Recent News from BioPharma + a 2023 Top WW 2023 List
This week we've had eyes on BioPharma happenings plus a 2023 Top Selling Drugs list.

jroele
Apr 4, 20222 min read
PharmaTell Studio Upgrades
We are excited to share the latest upgrades to PharmaTell Studio making it even easier for you to keep your eyes on you & your competition.


Robin Bateman
Mar 27, 20222 min read
FDA Approvals, Transcripts & Conferences
This week, the team has been looking at congress planners, earnings call transcripts, and the US FDA.


Robin Bateman
Mar 20, 20222 min read
Gene Therapy Guidance
This week, the team had Eyes on the new draft guidance from the US FDA on Gene Therapy Products Incorporating Genome Editing.


Robin Bateman
Mar 13, 20221 min read
Industry Intel
Today we’ll share some of the types of reports available that can help you keep your Eyes on Pharma Sectors.
bottom of page